Skip to main content

Involvement of Th17 and Th1 Effector Responses in Patients with Hepatitis B

Journal of Clinical Immunology volume 30, pages 546–555 (2010)Cite this article

Abstract

Background

Local production of cytokines within the liver may play a pivotal role in the regulation of pathophysiological processes during inflammation. CD4+ T cells are regarded as the most prolific cytokine producers. The purpose of this study was to quantify intrahepatic expression of Th1, Th2, Th17, and Treg-associated cytokines or transcription factors in patients with acute hepatitis B or chronic hepatitis B (CHB) and to analyze their relative roles in the promotion and regulation of hepatitis B virus (HBV)-associated liver diseases.

Methods

Distribution and expression of IL-17, IFN-γ, IL-4, Foxp3, and other cytokines in liver tissues were detected by immunohistochemistry and real-time quantitative PCR. Patients with hepatitis B were compared with patients with chronic hepatitis C, primary biliary cirrhosis, alcoholic liver cirrhosis, and healthy controls.

Results

The frequencies of intrahepatic IL-17 and IFN-γ-producing cells in patients with HBV-associated liver dysfunction were much higher than that of IL-4 and Foxp3-positive cells. The level of the IL-17/IFN-γ-positive cell ratio of patients with Child–Pugh class C (1.57 ± 0.09) was much higher than that of patients with Child–Pugh class B (1.00 ± 0.02) or A (0.93 ± 0.05). There are more IL-17-producing cells than IFN-γ-producing cells accumulating in the liver with severe hepatocellular damage. Liver IL-17-producing cell infiltration was positively associated with the grade of liver inflammation in CHB and positively correlated to intrahepatic IL-8 expression (r = 0.801, p < 0.01) or neutrophil infiltration (r = 0.917, p < 0.01).

Conclusions

These results suggest that the balance of effector CD4+ Th responses (Th17 and Th1 responses) and regulatory response is an important element of immune regulation. Inappropriate, excessive, and non-specific Th17 and Th1 effector responses may be involved in the pathogenesis of HBV-associated liver inflammation and hepatocellular damage. Th17 response, especially, may exacerbate the inflammatory processes leading to liver failure. IL-17-mediating liver neutrophil recruitment via induction of IL-8 may be one potential mechanism of liver injury in patients with hepatitis B. An improved understanding of the factors that influence the differentiation and function of these cell types in vivo will be of great importance to the future development of immune therapies in HBV-associated liver disease.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Reference

  1. Bettelli E, Carrier YJ, Gao WD, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector T(H)17 and regulatory T cells. Nature. 2006;441(7090):235–8.

    Article  CAS  PubMed  Google Scholar 

  2. Chisari FV, Hepatitis-B FC. Virus immunopathogenesis. Annu Rev Immunol. 1995;13:29–60.

    Article  CAS  PubMed  Google Scholar 

  3. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol. 1995;13:29–60.

    Article  CAS  PubMed  Google Scholar 

  4. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol. 2009;27:147–63.

    Article  CAS  PubMed  Google Scholar 

  5. Czaja AJ, Cookson S, Constantini PK, Clare M, Underhill JA, Donaldson PT. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology. 1999;117(3):645–52.

    Article  CAS  PubMed  Google Scholar 

  6. Fossiez F, Banchereau J, Murray R, Van Kooten C, Garrone P, Lebecque S. Interleukin-17. Int Rev Immunol. 1998;16(5–6):541–51.

    Article  CAS  PubMed  Google Scholar 

  7. Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. Journal of Hepatology. 2007;47(4):598–607.

    Article  PubMed  Google Scholar 

  8. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6(11):1123–32.

    Article  CAS  PubMed  Google Scholar 

  9. Jaeschke H, Hasegawa T. Role of neutrophils in acute inflammatory liver injury. Liver Int. 2006;26(8):912–9.

    Article  CAS  PubMed  Google Scholar 

  10. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27:485–517.

    Article  CAS  PubMed  Google Scholar 

  11. Koziel MJ. The immunopathogenesis of HBV infection. Antivir Ther. 1998;3 Suppl 3:13–24.

    CAS  PubMed  Google Scholar 

  12. Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999;162(4):2347–52.

    CAS  PubMed  Google Scholar 

  13. Lan RYZ, Salunga TL, Tsuneyama K, Lian ZX, Yang GX, Hsu W, et al. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun. 2009;32(1):43–51.

    Article  CAS  PubMed  Google Scholar 

  14. Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, Demetter P, et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009;49(2):646–57.

    Article  CAS  PubMed  Google Scholar 

  15. Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49(5 Suppl):S13–21.

    Article  CAS  PubMed  Google Scholar 

  16. Linden A. Role of interleukin-17 and the neutrophil in asthma. Int Arch Allergy Immunol. 2001;126(3):179–84.

    Article  CAS  PubMed  Google Scholar 

  17. Lohr HF, Weber W, Schlaak J, Goergen B, Zumbuschenfelde KHM, Gerken G. Proliferative response of CD4(+) T-cells and hepatitis-B virus clearance in chronic hepatitis with or without hepatitis -B E-minus hepatitis-B virus mutants. Hepatology. 1995;22(1):61–8.

    CAS  PubMed  Google Scholar 

  18. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009;49(5 Suppl):S45–55.

    Article  CAS  PubMed  Google Scholar 

  19. Nishimura T, Ohta A. A critical role for antigen-specific Th1 cells in acute liver injury in mice. J Immunol. 1999;162(11):6503–9.

    CAS  PubMed  Google Scholar 

  20. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6(11):1133–41.

    Article  CAS  PubMed  Google Scholar 

  21. Penna A, DelPrete G, Cavalli A, Bertoletti A, Delios MM, Sorrentino R, et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology. 1997;25(4):1022–7.

    Article  CAS  PubMed  Google Scholar 

  22. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005;5(3):215–29.

    Article  CAS  PubMed  Google Scholar 

  23. Ren F, Hino K, Yamaguchi Y, Funatsuki K, Hayashi A, Ishiko H, et al. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection. J Med Virol. 2003;71(3):376–84.

    Article  CAS  PubMed  Google Scholar 

  24. Rossol S, Marinos G, Carucci P, Singer MV, Williams R, Naoumov NV. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest. 1997;99(12):3025–33.

    Article  CAS  PubMed  Google Scholar 

  25. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med. 2007;13(2):139–45.

    Article  CAS  PubMed  Google Scholar 

  26. Takahashi H, Zeniya M, Watanabe F, Hayashi A, Hokari A, Aizawa Y, et al. Significance of intracellular Th1/Th2 cytokine analysis in chronic viral hepatitis. Hepatology. 1997;26(4):1926–6.

    Google Scholar 

  27. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev. 2008;223:87–113.

    Article  CAS  PubMed  Google Scholar 

  28. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol. 1995;13:251–76.

    Article  CAS  PubMed  Google Scholar 

  29. Vierling JM. The immunology of hepatitis B. Clin Liver Dis. 2007;11(4):727–59. vii-viii.

    Article  PubMed  Google Scholar 

  30. Wieland SF, Chisari FV. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol. 2005;79(15):9369–80.

    Article  CAS  PubMed  Google Scholar 

  31. Xiao MJ, Wang CH, Zhang JH, Li ZG, Zhao XQ, Qin ZH. IFN gamma promotes papilloma development by up-regulating Th17-associated inflammation. Cancer Res. 2009;69(5):2010–7.

    Article  CAS  PubMed  Google Scholar 

  32. Xu XW, Lu MH, Tan DM. Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin Microbiol Infect. 2005;11(1):52–6.

    Article  CAS  PubMed  Google Scholar 

  33. Yasumi Y, Takikawa Y, Endo R, Suzuki K. Interleukin-17 as a new marker of severity of acute hepatic injury. Hepatol Res. 2007;37(4):248–54.

    Article  CAS  PubMed  Google Scholar 

  34. Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, et al. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation. Ann Surg Oncol. 2008;15(12):3494–502.

    Article  PubMed  Google Scholar 

  35. Zhang JP, Yan J, Xu J, Pang XH, Chen MS, Li L, et al. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol. 2009;50(5):980–9.

    Article  CAS  PubMed  Google Scholar 

  36. Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L, et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010;51(1):81–91.

    CAS  PubMed  Google Scholar 

Download references

Sponsor and grant acknowledgements

This work was supported by grants from the National Basic Research Program of China (2009CB522403), National Natural Science Foundation of China (No. 30972795), and National Science and Technology Major Project of China (No. 2008ZX10002-22).

Author information

Affiliations

  1. Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People’s Republic of China

    Yufu Ye, Xiaojun Xie, Jiwei Yu, Lin Zhou, Haiyang Xie, Guoping Jiang, Xiaobo Yu, Wenjin Zhang, Jian Wu & Shusen Zheng

  2. Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People’s Republic of China

    Yufu Ye, Xiaojun Xie, Jiwei Yu, Lin Zhou, Haiyang Xie, Guoping Jiang, Xiaobo Yu, Wenjin Zhang, Jian Wu & Shusen Zheng

Authors
  1. Yufu Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaojun Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiwei Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lin Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Haiyang Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guoping Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiaobo Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Wenjin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jian Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Shusen Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shusen Zheng.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ye, Y., Xie, X., Yu, J. et al. Involvement of Th17 and Th1 Effector Responses in Patients with Hepatitis B. J Clin Immunol 30, 546–555 (2010). https://doi.org/10.1007/s10875-010-9416-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-010-9416-3

Keywords

  • IL-17
  • interferon-gamma
  • regulatory T cells
  • hepatitis B